Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2022.09.08

Sai Life Sciences Manchester announces recruitment drive to increase scientific team by 20%

Sai Life Sciences Manchester announces recruitment drive to increase scientific team by 20%

Commences recruitment for 15 positions across analytical, chemistry, engineering and particle sciences departments

Sai Life Sciences, today announced plans to grow the scientific team at its site in Manchester, UK by 20% and commenced the process of recruitment for 15 positions across analytical, chemistry, engineering and particle sciences departments. View open positions.

Making the announcement, Dr Dean Edney, Global Head of Process R&D at Sai Life Sciences said, “In a little over two years since we began in Manchester, our team has established a formidable reputation for itself as a high-quality scientific unit that can solve complex chemistry challenges. Our growing list of global innovator clients is a strong validation of our success. The present recruitment drive is aimed at increasing our scientific capacity to better serve the growing demand.”

In July 2020, Sai Life Sciences opened a new Centre of Excellence in Process Chemistry R&D in Alderley Park, Manchester to help accelerate the NCE development programmes of its global innovator customers. This Centre has since grown to become a reliable partner to many innovator companies across the world, providing high quality chemistry, non-GMP material delivery, and successful technology transfer to its sites in India for scale-up.

Now, with a growing interest from its customers for clinical API supplies from Manchester, work is underway to set-up a GMP Kilo Lab at the Manchester site. Scheduled to be commissioned in Q4-2022, the new facility will be capable of delivering GMP drug substance and intermediates, with the GMP equipment engineered to provide containment down to 1µg/m3.

As part of the SaiNxt transformation initiative, the company has executed investments of US$110M in expanding into new geographies, augmenting its capacity and operations, while raising the bar for quality, compliance and performance.

Share article

More News

2023.08.21

Sai Life Silver Jubilee year

Sai Life Sciences enters its Silver Jubilee year; surpasses vision of 25 commercial molecules by 2025

Sai Life Sciences entered its Silver Jubilee year with aplomb, surpassing its vision of supporting global innovator partners in bringing 25 new medicines to market by 2025. The company crossed this milestone two years ahead of schedule and is poised to sustain this momentum on the back of a strong portfolio of molecules at various […]
Read more

2023.06.22

SBTi

Sai Life Sciences joins Science Based Targets initiative (SBTi), commits to fight climate change with Science

To help combat climate change, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced joining Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science. Accordingly, it has committed to set near-term company-wide emission reductions in line with […]
Read more

2023.06.06

Commitment to Sustainability

Sai Life Sciences reaffirms commitment to Sustainability, charts out SDGs to be achieved by FY27

On the World Environment Day 2023, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced its renewed Sustainable Development Goals (SDG) charting out the roadmap to achieve specific environmental, social and governance (ESG) targets by the financial year ending March 31, 2027. Making the announcement, Krishna Kanumuri, CEO & Managing Director, […]
Read more

2023.04.20

SSRL inauguration

Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus

• Fully equipped labs with 75-member team set-up and made operational in <100 days Sai Life Sciences, one of India’s fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr. Karen Akinsanya, […]
Read more

2023.03.29

Sai Life Sciences & NIIT Foundation

Sai Life Sciences and NIIT Foundation partner to create livelihood opportunities for underserved communities in Hyderabad

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced entering into an agreement with NIIT Foundation, a not-for-profit education society, to implement youth career development programs for underserved communities in Hyderabad, Telangana. As part of the agreement, NIIT Foundation will develop and run multiple courses, and provide […]
Read more